全文获取类型
收费全文 | 45571篇 |
免费 | 3275篇 |
国内免费 | 160篇 |
专业分类
耳鼻咽喉 | 663篇 |
儿科学 | 1214篇 |
妇产科学 | 790篇 |
基础医学 | 6000篇 |
口腔科学 | 580篇 |
临床医学 | 4680篇 |
内科学 | 9628篇 |
皮肤病学 | 491篇 |
神经病学 | 4378篇 |
特种医学 | 1670篇 |
外科学 | 7571篇 |
综合类 | 839篇 |
现状与发展 | 1篇 |
一般理论 | 40篇 |
预防医学 | 3569篇 |
眼科学 | 588篇 |
药学 | 3107篇 |
中国医学 | 58篇 |
肿瘤学 | 3139篇 |
出版年
2023年 | 268篇 |
2022年 | 510篇 |
2021年 | 1164篇 |
2020年 | 658篇 |
2019年 | 1073篇 |
2018年 | 1295篇 |
2017年 | 871篇 |
2016年 | 1021篇 |
2015年 | 1237篇 |
2014年 | 1630篇 |
2013年 | 2161篇 |
2012年 | 3598篇 |
2011年 | 3666篇 |
2010年 | 2034篇 |
2009年 | 1823篇 |
2008年 | 3049篇 |
2007年 | 3124篇 |
2006年 | 3046篇 |
2005年 | 3084篇 |
2004年 | 2752篇 |
2003年 | 2606篇 |
2002年 | 2362篇 |
2001年 | 401篇 |
2000年 | 281篇 |
1999年 | 380篇 |
1998年 | 487篇 |
1997年 | 423篇 |
1996年 | 347篇 |
1995年 | 335篇 |
1994年 | 289篇 |
1993年 | 263篇 |
1992年 | 232篇 |
1991年 | 199篇 |
1990年 | 179篇 |
1989年 | 171篇 |
1988年 | 161篇 |
1987年 | 137篇 |
1986年 | 129篇 |
1985年 | 122篇 |
1984年 | 135篇 |
1983年 | 113篇 |
1982年 | 146篇 |
1981年 | 152篇 |
1980年 | 106篇 |
1979年 | 74篇 |
1978年 | 72篇 |
1977年 | 71篇 |
1976年 | 60篇 |
1975年 | 54篇 |
1973年 | 57篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
Reduction potentials were determined for various anticonvulsants, including progabide, SL 75.102, CGS 9896, pyridazines, zonisamide, 1,2,3-triazoles, and copper complexes. The values generally were in the range of about -0.1 to -0.6 V for the protonated drugs and the metal complexes. Reduction potentials provide information on the feasibility of electron transfer (ET) in vivo. If the value is relatively positive (greater than about -0.6 V), the agent can act catalytically as an electron acceptor from an appropriate cellular donor. A concomitant favorable influence on abnormal neuronal processes associated with epilepsy could occur. We describe ET as a possible mode of action of anticonvulsants as well as some antiepileptic agents with no electrochemical data based on this hypothetical ET approach. 相似文献
102.
William Davies Mohammad Jazayeri Patrick Tchou 《Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy》1988,2(3):283-286
Summary Encainide is a type Ic antiarrhythmie agent. During encainide therapy, mild Q-T interval prolongation can be seen, usually associated with prolongation of the Q-R-S interval. The present case report describes an unusual and marked prolongation of the Q-T interval with no Q-R-S interval prolongation in a patient who was treated with encainide for atrioventricular nodal reentrant tachycardia. The drug metabolite profile in this patient's serum indicated an unusual elevation of the 3-methoxy-O-demethyl encainide metabolite, versus O-demethyl encainide. This elevated metabolite level suggests that 3-methoxy-O-demethyl encainide has a significant effect on prolongation of repolarization. An abnormal metabolism of encainide may be the underlying mechanism by which some patients would manifest an unusual prolongation of Q-T interval during encainide therapy. 相似文献
103.
104.
105.
106.
Patrick Sullivan 《Canadian Medical Association journal》1995,152(2):253-255
Potential changes to registered retirement savings plan (RRSP) regulations “continue to generate a huge amount of concern” among physicians, the Board of Directors was told at its December meeting. That anxiety explains why the RRSP issue and related lobbying will remain at the top of the CMA's priority list in 1995. The other major topic of concern during the 3-day meeting was the federal government's proposed gun-control legislation. If doctors are going to have a responsibility to report patients whose ownership of firearms may make them a danger to themselves or others, the CMA wants to ensure that physicians who make such reports are protected under the law. 相似文献
107.
Exposure of H69 small cell lung carcinoma cells to nicotinic agonists resulted in a significant increase (up to 100%) in cell number after 6 to 12 days. The effect of nicotine (10−8 M to 10−4 M) was both dose and time dependent as was that of another nicotinic agonist cytisine (10−6 M to 10−4 M). Interstingly, both the nicotine and cytisine induced increases in H69 cell number were blocked by α-bungarotoxin, as well as d-tubocurarine a nicotinic blocker which appears to interact with most nicotinic receptors. These results suggest that the nicotine induced increase in cell number is mediated through an interaction at the nicotinic α-bungarotoxin receptor. This idea is further supported by experiments which show (1) that H69 cells possess high affinity α-bungarotoxin sites (Kd = 25 nM, Bmax = 10.4 fmol/106 cells) with the characteristics of a nicotinic α-bungarotoxin receptor and (2) that the potencies of nicotinic receptor ligands in the α-bungarotoxin binding assay were similar to those observed in the functional studies. Northern analysis showed that mRNA for α7, a putative nicotinic α-bungarotoxin binding subunit, and for α5 were present in H69 cells. The present data provide further evidence that nicotine increases cell number in small cell lung carcinoma and are the first to show that this effect is mediated through an interaction at the nicotinic α-bungarotoxin receptor population. These results suggest that the α-bungarotoxin site may be involved in modulating proliferative responses in neuroendocrine derived SCLC cells. 相似文献
108.
109.
Jerry Z. Finklestein Mark D. Krailo Carl Lenarsky Stephen Ladisch Geoffrey K. Blair C. Patrick Reynolds Anneliese L. Sitarz G. Denman Hammond 《Pediatric blood & cancer》1992,20(4):307-311
The Childrens Cancer Study Group evaluated daily oral 13-cis-retinoic acid to determine its therapeutic efficacy in 28 children with advanced neuroblastoma refractory to conventional therapy. Cheilitis and fissured lips were the most common side effects; however, fewer than 50% of the patients experienced any toxicity. Two of twenty-two evaluable children demonstrated positive response to therapy. In one case, a child received the drug for 11 months. Seventeen patients demonstrated progressive disease within 28 days of the start of treatment. Three other patients with stable disease, or removed from study at day 28, were considered nonresponsive. Our data demonstrate that, when given as a single daily oral dose of 100 mg/m2, 13-cis-retinoic acid does not have significant activity in children with advanced neuroblastoma. © 1992 Wiley-Liss, Inc. 相似文献
110.
Zvi Laron Jenny Frenkel lrit Gil-Ad Beatrice Klinger Ernesto Lubin Patrick Wuthrich François Boutignon Vincent Lengerts Romano Deghenghi 《Clinical endocrinology》1994,41(4):539-541
OBJECTIVE Hexarelin is a new synthetic growth hormone releasing peptide. We have tested the efficacy of intranasal (i.n.) administration of hexarelin to stimulate plasma GH and have compared this to the intravenous (i.v.) administration of the peptide. PATIENTS Ten children with familial short stature (FSS) aged 5·5-15·5 years and two known GH deficient patients aged 24 and 28 years without GH treatment. METHODS All 12 subjects were submitted to i.v. (1 μg/kg) and i.n. (20 μg/kg) hexarelin tests with a one-week interval between tests. Blood samples for GH, TSH, fT4 and T3 were obtained at 0, 15, 30, 60, 90 and 120 minutes. The hormone determinations were made by standard radio-immunoassays (RIA). RESULTS Both the i.n. and i.v. administration of hexarelin induced a large GH response, the mean (±SD) being 72·2± 35·5 mU/l for the i.n. test and 79·6 ± 53·0 mU/l for the i.v. test. The peak GH in the i.v. test occurred at 15–30 minutes and in the i.n. test between 30 and 60 minutes. The GH deficient patients showed no GH response In either test. Plasma TSH decreased in the FSS children from a mean (±SD) of 1.0 ± 0·26 to 0·64±0 2 mU/l (P<0 005) during the i.n. test and from 1·0±0·3 to 0·7±0·3mU/l (P> 0 05) during the I.v. test. In the isolated GH deficient patient, plasma TSH decreased from 1·06±0·38 mU/l to 0·86±0·17 during the i.v. test and from 1·60±0·01 to 1·11±0·06mU/l during the i.n. test. There were no significant changes in plasma fT4 or T3 in any of the tests. CONCLUSIONS The synthetic hexapeptide hexarelin is a potent pituitary GH stimulator when administered intra-nasally. The GH response was similar to that observed after intravenous hexarelin. Simultaneously, there was a significant decrease in plasma TSH but the concentrations remained in the normal range. These findings appear to be of theoretical and practical relevance to the investigation and management of short children. 相似文献